CAGR biotech companies market cap U.S. 2012-2016

Market capitalization compound annual growth rate of selected U.S. biotech companies between 2012 and 2016

Market cap CAGR of biotech companies in the U.S. 2012-2016

Last update:

Jun 29, 2017

Author:

��ƽ�� Research Department

Region:

United States

Survey time period:

From 01/01/2012 to 31/12/2016

This statistic displays the CAGR of selected biotechnology companies' market capitalization in the United States between 2012 and 2016. During this period, Amgen had a CAGR of 21 percent. Revenues of the United States' biotechnology market has grown over the last 15 years.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Market capitalization compound annual growth rate of selected U.S. biotech companies between 2012 and 2016

Get in touch with us for additional information

��ƽ��